BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18836991)

  • 1. Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease.
    Shively SB; Beltaifa S; Gehrs B; Duong H; Smith J; Edwards NA; Lonser R; Raffeld M; Vortmeyer AO
    J Pathol; 2008 Dec; 216(4):514-20. PubMed ID: 18836991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of VHL tumourigenesis in nerve root tissue.
    Vortmeyer AO; Tran MG; Zeng W; Gläsker S; Riley C; Tsokos M; Ikejiri B; Merrill MJ; Raffeld M; Zhuang Z; Lonser RR; Maxwell PH; Oldfield EH
    J Pathol; 2006 Nov; 210(3):374-82. PubMed ID: 16981244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.
    Shively SB; Falke EA; Li J; Tran MG; Thompson ER; Maxwell PH; Roessler E; Oldfield EH; Lonser RR; Vortmeyer AO
    Mod Pathol; 2011 Aug; 24(8):1023-30. PubMed ID: 21499240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
    Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
    Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
    Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study.
    Sobottka SB; Frank S; Hampl M; Schackert HK; Schackert G
    Acta Neurochir (Wien); 1998; 140(3):281-5. PubMed ID: 9638266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
    Vortmeyer AO; Frank S; Jeong SY; Yuan K; Ikejiri B; Lee YS; Bhowmick D; Lonser RR; Smith R; Rodgers G; Oldfield EH; Zhuang Z
    Cancer Res; 2003 Nov; 63(21):7051-5. PubMed ID: 14612494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.
    Wang Y; Abu-Asab MS; Shen D; Zhuang Z; Chew EY; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1319-27. PubMed ID: 24859386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
    Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.
    Chan CC; Chew EY; Shen D; Hackett J; Zhuang Z
    Mol Vis; 2005 Sep; 11():697-704. PubMed ID: 16163267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental effects of von Hippel-Lindau gene deficiency.
    Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
    Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.